AI assistant
CVS HEALTH Corp — Director's Dealing 2021
Jan 12, 2021
29875_dirs_2021-01-12_e3807f9a-0898-4a13-8293-77bec17a83f7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2021-01-08
Reporting Person: Brennan Troyen A (EVP and Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-01-08 | Common Stock | S | 58896 | $75.00 | Disposed | 46008.059 | Direct |
| 2021-01-08 | Common Stock | M | 54550 | $74.29 | Acquired | 100558.059 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-01-08 | Stock Option | $74.29 | M | 54550 | Disposed | 2021-04-01 | Common Stock (54550) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (restricted) | 8383 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $102.26 | 2022-04-01 | Common Stock (47937) | 47937 | Direct |
| Stock Option | $104.82 | 2023-04-01 | Common Stock (53772) | 53772 | Direct |
| Stock Option | $78.05 | 2024-04-03 | Common Stock (75134) | 75134 | Direct |
| Stock Option | $62.21 | 2025-04-01 | Common Stock (87575) | 87575 | Direct |
| Stock Option | $54.19 | 2029-04-01 | Common Stock (161605) | 161605 | Direct |
| Stock Option | $58.34 | 2030-04-01 | Common Stock (112637) | 112637 | Direct |
Footnotes
F1: All sales were effected pursuant to a Rule 10b5-1 plan.
F2: Option became exercisable in four equal annual installments, commencing 4/1/2015.
F3: Option became exercisable in four equal annual installments, commencing 4/1/2016.
F4: Option became exercisable in four equal annual installments, commencing 4/1/2017.
F5: Option became exercisable in four equal annual installments, commencing 4/3/2018.
F6: Option became exercisable in four equal annual installments, commencing 4/1/2019.
F7: Option became exercisable in four equal annual installments, commencing 4/1/2020.
F8: The number of shares subject to the option were calculated using a 30-day average price.
F9: Option becomes exercisable in four equal annual installments, commencing 4/1/2021.